The role of clonal communication and heterogeneity in breast cancer
Ana Martín-Pardillos,
Ángeles Valls Chiva,
Gemma Bande Vargas,
Pablo Hurtado Blanco,
Roberto Piñeiro Cid,
Pedro J. Guijarro,
Stefan Hümmer,
Eva Bejar Serrano,
Aitor Rodriguez-Casanova,
Ángel Diaz-Lagares,
Josep Castellvi,
Samuel Miravet-Verde,
Luis Serrano,
María Lluch-Senar,
Víctor Sebastian,
Ana Bribian,
Laura López-Mascaraque,
Rafael López-López,
Santiago Ramón y Cajal
Affiliations
Ana Martín-Pardillos
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Ángeles Valls Chiva
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Gemma Bande Vargas
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Pablo Hurtado Blanco
Cancer Modelling Lab, Roche-CHUS Joint Unit
Roberto Piñeiro Cid
CIBERONC (Centro de Investigación Biomédica en Red de Cáncer)
Pedro J. Guijarro
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Stefan Hümmer
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Eva Bejar Serrano
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Aitor Rodriguez-Casanova
Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS)
Ángel Diaz-Lagares
CIBERONC (Centro de Investigación Biomédica en Red de Cáncer)
Josep Castellvi
Hospital Vall d’Hebron, Anatomía Patológica
Samuel Miravet-Verde
EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), The Institute of Science and Technology
Luis Serrano
EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), The Institute of Science and Technology
María Lluch-Senar
EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), The Institute of Science and Technology
Víctor Sebastian
Department of Chemical Engineering, Aragon Institute of Nanoscience (INA), University of Zaragoza
Ana Bribian
Department of Molecular, Cellular and Developmental Neurobiology, Instituto Cajal-CSIC
Laura López-Mascaraque
Department of Molecular, Cellular and Developmental Neurobiology, Instituto Cajal-CSIC
Rafael López-López
Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS)
Santiago Ramón y Cajal
Translational Molecular Pathology Group, Vall d’Hebron Research Institute
Abstract Background Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further amplified through specific interactions between cancer cells. We aimed to dissect the molecular mechanisms underlying the cooperation between different clones. Methods We produced clonal cell lines derived from the MDA-MB-231 breast cancer cell line, using the UbC-StarTrack system, which allowed tracking of multiple clones by color: GFP C3, mKO E10 and Sapphire D7. Characterization of these clones was performed by growth rate, cell metabolic activity, wound healing, invasion assays and genetic and epigenetic arrays. Tumorigenicity was tested by orthotopic and intravenous injections. Clonal cooperation was evaluated by medium complementation, co-culture and co-injection assays. Results Characterization of these clones in vitro revealed clear genetic and epigenetic differences that affected growth rate, cell metabolic activity, morphology and cytokine expression among cell lines. In vivo, all clonal cell lines were able to form tumors; however, injection of an equal mix of the different clones led to tumors with very few mKO E10 cells. Additionally, the mKO E10 clonal cell line showed a significant inability to form lung metastases. These results confirm that even in stable cell lines heterogeneity is present. In vitro, the complementation of growth medium with medium or exosomes from parental or clonal cell lines increased the growth rate of the other clones. Complementation assays, co-growth and co-injection of mKO E10 and GFP C3 clonal cell lines increased the efficiency of invasion and migration. Conclusions These findings support a model where interplay between clones confers aggressiveness, and which may allow identification of the factors involved in cellular communication that could play a role in clonal cooperation and thus represent new targets for preventing tumor progression.